Articles tagged with Analgesics
Experts call for decriminalization of drug users, alongside a massive scale-up of opioid substitution, needle and syringe programs, and antiretroviral treatment. Current treatment programmes only reach around 10% of people who use drugs worldwide, highlighting the need for reform in justice systems and policy decision making.
The ASPREE study aims to assess whether aspirin can prolong a life free of physical disability and dementia in healthy older people. The trial will enroll 6,500 participants in the US and Australia and monitor changes in health markers, functional ability, and cognitive function over five years.
A pre-emptive multimodal pain regimen reduced opioid analgesic use in robotic prostatectomy patients. The study found a mean opioid dose of 49.1 mg for those receiving the regimen, compared to 75.3 mg for standard care.
Researchers have discovered a new group of drugs that could provide effective cancer pain relief with minimal side effects. The drugs, developed in collaboration between the Universities of Leicester and Ferrara, act on two targets simultaneously to reduce tolerance.
A recent study found that patients taking celecoxib (a COX-2 selective NSAID) had lower rates of gastrointestinal adverse events compared to those taking diclofenac slow release plus omeprazole. The CONDOR study suggests that celecoxib may be a safer option for arthritis patients at increased gastrointestinal risk.
A systematic review shows that topical non-steroidal anti-inflammatory drugs (NSAIDs) are more effective than placebos for treating short-term pain, reducing pain by 50% or more in over six out of ten cases. The researchers found that topical diclofenac, ibuprofen, ketoprofen, and piroxicam provided the best results with few side effects.
A European survey found that up to 45% of cancer patients with breakthrough pain do not adhere to medication despite severe episodes. Patients want medications that relieve pain quickly and cause few side effects, yet current treatments often fail to meet these needs.
Experts now advise against low-dose aspirin therapy for men under 50 and women under 60 with diabetes, citing risks of stomach bleeding and other side effects. Generic medications for high blood pressure and cholesterol control may be more effective in preventing heart attacks.
Research reveals that group visits can significantly improve blood pressure in diabetics with hypertension but not blood sugar levels. Colorectal cancer risk increases with age and birth cohort, suggesting a potential burden to society. Opioid treatment agreements may not reduce misuse, and a new complication from contaminated cocaine ...
The review article provides a comprehensive guide to pain management in cirrhotic patients, recommending reduced dosing of acetaminophen and avoiding NSAIDs due to risk of acute renal failure. The authors emphasize the need for diligent follow-up for toxicity and adverse effects.
A study by Boston University School of Medicine identified factors associated with prescription drug use disorder (PDUD) in primary care patients with chronic pain. Key findings include a history of jail time, disabling pain, cigarette smoking, and family history of substance abuse as predictors of PDUD.
Rush University Medical Center is conducting an international clinical trial to test celecoxib's effectiveness in preventing precancerous polyps in children with familial adenomatous polyposis. The five-year study aims to assess whether the drug can reduce or prevent polyp formation, offering hope for these patients.
Researchers have developed a Mouse Grimace Scale to measure spontaneous responses in mice resembling human pain expressions. The scale accelerates the development of new analgesics for humans while eliminating unnecessary suffering in lab animals.
Researchers at Duke Clinical Research Institute found that telaprevir significantly improves response rates in patients with difficult-to-treat hepatitis C cases. The study also suggests a potential link between aspirin use and the development of inflammatory bowel disease, including Crohn's disease.
A new study by the University of East Anglia found that regular aspirin use increases the risk of developing Crohn's disease by five times. The research, which followed 200,000 volunteers, suggests that aspirin may be a contributing factor to the development of this debilitating condition.
Researchers found biochemical mediators of inflammation produced by activated macrophages, which stimulate antioxidant and anti-inflammatory responses. These findings could lead to the development of new treatments for inflammatory diseases linked to omega-3 fatty acids and aspirin.
Nearly 85% of teens in a study would have overdosed on acetaminophen if given the option, despite 60% having never heard of it. Limited health literacy increases this risk even further.
Dr. Joel Hirsch's research provides new information on how calcium channels work and offers a framework for designing drugs that can modulate them to provide relief from chronic pain. The discovery has the potential to lead to new treatments for conditions such as backaches, sore limbs, and arthritis.
Researchers at the University of Texas Health Science Center have discovered a family of endogenous capsaicin-like molecules that play an important role in pain biology. They have developed two new classes of analgesics using drugs that either block the synthesis or inactivate these substances.
Telcagepant, a CGRP receptor blocker, provides similar pain relief as triptans but with fewer cardiovascular risks. Topiramate may also prevent migraine attacks in chronic sufferers.
A single dose of aspirin (900-1000mg) significantly reduces migraine headache pain in over half of people, with added metoclopramide improving nausea and vomiting symptoms. Aspirin plus metoclopramide is a reasonable option for acute migraine attacks, but may not be effective enough for some.
Researchers found that nicotine withdrawal syndrome is more common in agitated smokers than non-smokers, increasing risks of accidental tube removals. The study highlights the need for improved strategies to prevent agitation or treat it earlier in critically ill patients.
Researchers found dilated intercellular spaces in esophageal epithelium as a nonspecific ultrastructural feature of non-erosive reflux disease (NERD). This discovery suggests DIS is an early and sensitive marker for NERD diagnosis, providing new insights into its mechanism.
The new center will provide timely data on prescriptions to doctors, pharmacies, and regulatory agencies, helping identify best practices in prescription monitoring. The initiative aims to reduce the serious epidemic of drug abuse, taking thousands of lives.
Researchers at the University of Leeds have discovered how two proteins manipulate nerve cells to send pain signals, offering a new target for painkillers. This breakthrough could lead to more effective and safer pain treatments by targeting peripheral nervous system.
A new ultra-rapid acting mealtime insulin is orally inhaled for absorption via the lung, mimicking the natural early insulin response. This innovative technology uses a delivery system that applies to other drugs currently injected, with potential benefits including reduced hypoglycemia and weight gain.
Researchers have discovered a new drug that targets the root cause of painful menstrual cramps, called dysmenorrhea. The compound, VA111913, has shown promise in Phase II clinical trials and could be available to patients in four years if studies continue to show positive results.
A study of nearly 1,500 patients over seven years found that vertebroplasty significantly improves back pain within hours and provides long-term pain relief. Collaboration between interventional radiologists and medical experts is crucial for the best results.
Researchers have discovered the unique genes responsible for codeine and morphine production in the opium poppy, opening doors to alternative methods of producing these painkillers. The findings could lead to more efficient and cost-effective synthesis of pharmaceuticals using microorganisms.
A novel protein named haditoxin has been identified in King Cobra venom, showing promise for new drug discovery and advancing our understanding of disease mechanisms. The protein's unique structure suggests it may offer insights into treating various neurological disorders.
A study published in the Journal of Patient Safety found that non-traditional therapies can significantly impact pain levels in hospitalized patients, with reductions of up to 50%. The treatments included mind-body therapies, acupuncture, and massage, among others, which were found to be effective across various patient populations.
A study found that individuals with a low ankle-brachial index (ABI) did not significantly reduce their risk of cardiovascular or cerebrovascular events with aspirin use. Alternative therapies, such as statins or more potent antiplatelet agents, may be considered for these high-risk patients.
A European study finds inadequate access to opioid-based pain relief for cancer patients, with some countries restricting essential medicines. The authors conclude that restrictive regulations hinder medical care and recommend revising laws to improve accessibility.
A study published in the American Journal of Roentgenology found that the risk of major bleeding after image-guided percutaneous biopsies is low, even among patients taking aspirin. The study reviewed 15,181 biopsies performed over six years and found only 70 hemorrhages (0.5%) within three months of biopsy.
A new study found that women with low sexual desire experience personal and emotional distress, including negative emotions like dissatisfaction and guilt. The study identified 5,098 women with low sexual desire, who reported significant correlations between their level of desire and associated distress.
A study of 136,474 participants found that regular ibuprofen users were 40% less likely to develop Parkinson's disease. Higher doses of ibuprofen also showed a reduced risk of developing the disease.
According to a study published in Archives of Dermatology, regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with an increased risk of squamous cell skin cancer. The study found that NSAID users were not at a higher risk for squamous cell carcinoma regardless of duration or dose.
A study published in the journal Thorax found that prenatal acetaminophen exposure is associated with an increased risk of asthma symptoms in children. The relationship was strongest in children with a variant of the glutathione S transferase gene involved in detoxification.
Researchers at Vanderbilt University Medical Center have discovered that acetaminophen can prevent oxidative damage and kidney failure after muscle injury in a rat model. The study's findings support further investigation into the drug's effects in patients with severe muscle injuries.
Researchers at the University of Liverpool have discovered a single low dose infusion of intravenous immunoglobulin (IVIG) significantly reduces pain in patients with Complex Regional Pain Syndrome (CRPS), improving quality of life. The treatment has few adverse effects and can be repeated every four weeks.
Research suggests NSAIDs like ibuprofen may be more effective for relieving period pain compared to paracetamol. The updated review of 73 trials involving 5,156 women found that NSAIDs are very effective for treating period pain, with some evidence suggesting they work better than paracetamol.
Research suggests that low vitamin D levels are an independent risk factor for cardiovascular disease and may contribute to higher cardiovascular risk among blacks. The study found that accounting for vitamin D levels reduced the race-based risk of cardiovascular mortality by 60 percent.
The International Headache Society has published new research guidelines to stimulate more research into headache treatment and reduce health risks associated with treatment. The guidelines focus on episodic and chronic tension-type headaches, aiming to identify more effective treatments and improve clinical trial safety for patients.
Health consumers must become informed advocates for comprehensive pain treatment as physicians struggle with inadequate training and fear of prescription drug abuse. Long-term solutions require education, responsibility, and collaboration among all parties involved.
A new study at Ben-Gurion University reveals that taking coxib medications like Celebrex with aspirin increases the risk of cardiovascular events. Researchers found that coxibs interfere with aspirin's effectiveness in preventing blood clots, potentially offsetting its protective benefits.
A study found that acetaminophen reduced self-reported social pain and neural responses to social rejection in brain regions associated with physical pain. The findings suggest that acetaminophen may mitigate the distress of social rejection, potentially reducing antisocial behavior.
A new study suggests that combining celebrex with low-dose aspirin may reduce the effectiveness of aspirin in preventing heart attack and stroke. Researchers found that celebrex interferes with aspirin's ability to block blood clots, particularly when taken in low doses.
A study found that 44% of patients believe they are receiving a medication they don't need, and 96% cannot recall at least one prescribed medication. The study highlights the importance of patient knowledge in preventing medication errors.
The American Society for Gastrointestinal Endoscopy has issued new guidelines for managing antithrombotic agents during endoscopic procedures. Aspirin and NSAIDs may be continued for all elective procedures, while temporary anticoagulation therapy should be completed before proceeding.
A new study found that opioid-related deaths in Ontario, Canada have doubled since 1991, with a significant increase in oxycodone-related deaths. Most of these additional deaths were accidental, and the study suggests that increased rates of opioid prescriptions are a major factor in these deaths.
A study found no association between antiepileptic drugs and increased suicidal thoughts or actions in individuals with bipolar disorder. In fact, antiepileptic drug treatment may have a protective effect on suicidality, particularly among those not receiving other treatments.
A study led by St. Michael's Hospital found that deaths from opioid use in Ontario doubled between 1991 and 2004, with a five-fold increase in oxycodone-related deaths after OxyContin was introduced in 2000. Most opioid-related fatalities were accidental, and most people who died had visited a doctor recently.
Recent studies on anticoagulants suggest that aspirin and heparin may not be effective in preventing unexplained, recurrent miscarriages. In contrast, a new study shows that dabigatran etexilate is as safe and effective as warfarin for treating venous thromboembolism.
A UCLA study found that nearly 20% of stroke survivors were not taking antithrombotic medications, with non-Hispanic, older, and male patients more likely to be on these medications. The study suggests further research is needed to understand the reasons behind this disparity in medication adherence.
A randomized study found that percutaneous disc decompression provides sustained pain relief up to two years, while conservative therapy only offers short-term benefits. Disc decompression involves deflating the bulging disc and relieving nerve root pressure, allowing for improved mobility and quality of life.
University of Missouri researchers found that aspirin and Tylenol block enzymes that inhibit vaccines. This could lead to reduced antibody responses and decreased protection against infections.
Despite increased availability of prescription antiplatelet medications, the overall use of blood-thinning agents among stroke survivors has plateaued. Aspirin remains the predominant agent used for secondary stroke prevention, with no improvements in antithrombotic agent usage over a 7-year period.
A recent study found that low-dose aspirin may offer mild protection from AMD, reducing the risk by 18% in women who took the medication. However, statins did not show a significant impact on advanced AMD risk, with patients taking statins actually at a slightly higher risk of developing advanced disease.
A new self-assessment score has been developed to predict diabetes risk, showing promise as a simple and effective tool. Additionally, researchers are considering alternative bacteria, Fusobacterium necrophorum, for sore throat treatment due to its association with a rare but life-threatening complication, Lemierre syndrome. Furthermor...
Researchers at Newcastle University have scientifically proven the pain-relieving properties of Hyptis crenata, a traditional South American herb. The study showed that the herbal tea was as effective as Indometacin in relieving pain, with results comparable to synthetic aspirin-style drugs.